Australia's Invion gains on new medical technology license

Invion

03/12/2025 24:13

** Shares of Invion IVX.AX rise as much as 39.2% to A$0.110, rising most since August 19

** Biotech co secures an expanded portfolio of perpetual exclusive global licenses to the Photosoft technology

** Photosoft platform licenses cover a broad portfolio of human and animal diseases, including cancers and infectious diseases

** Stock at highest since October 16

** Over 389,000 shares change hands, compared with the 30-day average volume of 49,486

** Stock currently up 32.9%, bringing YTD losses to 62.5%

 (Reporting by Adwitiya Srivastava in Bengaluru)

 ((Adwitiya.Srivastava@thomsonreuters.com))